Brown, Lisle/Cummings’s Repligen RGEN Stock Holding History

Brown, Lisle/Cummings’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.23K	Hold	31	–	–	﹤0.01%	734
2026 Q1	$3.65K	Buy	+31	New	+$4.33K	﹤0.01%	723

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Brown, Lisle/Cummings's RGEN Position: Q2 2026 in Review

Brown, Lisle/Cummings held its Repligen (RGEN) position steady in Q2 2026 at 31 shares worth $4.23K. The position accounts for ﹤0.01% of the portfolio, ranked #734.

Brown, Lisle/Cummings first reported a position in RGEN in Q1 2026 and has held it in 2 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Brown, Lisle/Cummings held 31 shares of Repligen worth $4.23K as of Q2 2026.
Brown, Lisle/Cummings left its Repligen share count unchanged in Q2 2026.
Repligen made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #734 holding.
Brown, Lisle/Cummings first reported a position in Repligen in Q1 2026 and has held it in 2 quarters since.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.